Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Review the indications and contraindications before booking
However, severe cases can progress to gastroparesis, which requires medical attention
A simpler schematic methodology described in Fig
In the OASIS 4 trial, serious adverse events were less frequent with the oral formulation ( 3.9% ) than with placebo (8.8%)
Pharmacokinetic Parameters Clinical Uses Monotherapy in T2DM when diet and exercise alone are insufficient Combination therapy with metformin, sulfonylureas, or insulin Particularly useful in patients at risk of hypoglycemia or needing once-daily dosing Adverse Effects Typically well tolerated Possible nasopharyngitis, headache, upper respiratory symptoms Rare: pancreatitis, hypersensitivity reactions Low risk of hypoglycemia when used alone Comparative Analysis MCQs Januvia inhibits which enzyme
US$ 26.73
US$ 27.14
US$ 26.91
US$ 21.90
US$ 28.33
US$ 25.15
US$ 27.18
US$ 25.45
US$ 21.79
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
